PTC Therapeutics Inc (PTCT) Insider Trading
- $31,673,582.00
- $179,522,421.48
- April 6, 2026
- Mark Elliott Boulding
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| April 19, 2022 | COO | 897 | $42.52 | Sell | $38,140.44 | |
| April 19, 2022 | Insider | 822 | $42.52 | Sell | $34,951.44 | |
| April 14, 2022 | CEO | 82 | $45.28 | Sell | $3,712.96 | |
| April 13, 2022 | VP | 2,276 | $45.17 | Sell | $102,806.92 | |
| April 5, 2022 | VP | 5 | $45.00 | Sell | $225.00 | |
| March 31, 2022 | CFO | 7,910 | $37.78 | Sell | $298,839.80 | |
| Feb. 10, 2022 | VP | 17,935 | $45.03 | Sell | $807,613.05 | |
| Feb. 1, 2022 | Insider | 367 | $40.00 | Sell | $14,680.00 | |
| Feb. 1, 2022 | CAO | 313 | $40.00 | Sell | $12,520.00 | |
| Feb. 1, 2022 | CEO | 1,961 | $40.00 | Sell | $78,440.00 | |
| Feb. 1, 2022 | VP | 779 | $40.00 | Sell | $31,160.00 | |
| Feb. 1, 2022 | CFO | 553 | $40.00 | Sell | $22,120.00 | |
| Jan. 25, 2022 | CEO | 330 | $39.31 | Sell | $12,972.30 | |
| Jan. 25, 2022 | Insider | 359 | $39.31 | Sell | $14,112.29 | |
| Jan. 25, 2022 | CFO | 211 | $39.31 | Sell | $8,294.41 | |
| Jan. 18, 2022 | CAO | 11,428 | $43.94 | Sell | $502,146.32 | |
| Jan. 7, 2022 | Insider | 756 | $38.52 | Sell | $29,121.12 | |
| Jan. 7, 2022 | CFO | 800 | $38.52 | Sell | $30,816.00 | |
| Jan. 7, 2022 | CAO | 747 | $38.52 | Sell | $28,774.44 | |
| Jan. 7, 2022 | VP | 885 | $38.52 | Sell | $34,090.20 | |
| Jan. 4, 2022 | Insider | 64 | $41.16 | Sell | $2,634.24 | |
| Jan. 4, 2022 | CEO | 378 | $41.16 | Sell | $15,558.48 | |
| Jan. 4, 2022 | CFO | 173 | $41.16 | Sell | $7,120.68 | |
| Aug. 13, 2021 | Director | 1,650 | $40.06 | Sell | $66,099.00 | |
| July 8, 2021 | VP | 7,805 | $45.22 | Sell | $352,942.10 | |
| June 9, 2021 | Director | 365 | $41.88 | Sell | $15,286.20 | |
| April 19, 2021 | Insider | 786 | $48.17 | Sell | $37,861.62 | |
| Feb. 1, 2021 | CFO | 541 | $56.96 | Sell | $30,815.36 | |
| Feb. 1, 2021 | CAO | 368 | $56.96 | Sell | $20,961.28 | |
| Feb. 1, 2021 | CAO | 368 | $56.96 | Sell | $20,961.28 | |
| Feb. 1, 2021 | Director | 506 | $56.96 | Sell | $28,821.76 | |
| Feb. 1, 2021 | VP | 778 | $56.96 | Sell | $44,314.88 | |
| Feb. 1, 2021 | Insider | 973 | $56.96 | Sell | $55,422.08 | |
| Feb. 1, 2021 | CEO | 1,968 | $56.96 | Sell | $112,097.28 | |
| Jan. 25, 2021 | CFO | 275 | $62.05 | Sell | $17,063.75 | |
| Jan. 25, 2021 | Insider | 541 | $63.15 | Sell | $34,164.15 | |
| Jan. 25, 2021 | CEO | 350 | $62.05 | Sell | $21,717.50 | |
| Jan. 15, 2021 | Insider | 4,300 | $69.09 | Sell | $297,087.00 | |
| Jan. 8, 2021 | CFO | 26,033 | $69.75 | Sell | $1,815,801.75 | |
| Jan. 7, 2021 | Insider | 3,886 | $68.98 | Sell | $268,056.28 | |
| Jan. 5, 2021 | CEO | 1,402 | $62.37 | Sell | $87,442.74 | |
| Jan. 5, 2021 | CAO | 316 | $62.37 | Sell | $19,708.92 | |
| Jan. 5, 2021 | CFO | 288 | $62.37 | Sell | $17,962.56 | |
| Jan. 5, 2021 | insider | 1,067 | $62.37 | Sell | $66,548.79 | |
| Jan. 5, 2021 | VP | 772 | $62.37 | Sell | $48,149.64 | |
| Dec. 30, 2020 | CEO | 285,718 | $61.74 | Sell | $17,640,229.32 | |
| Dec. 8, 2020 | Director | 687 | $62.52 | Sell | $42,951.24 | |
| Dec. 7, 2020 | CEO | 348,417 | $61.00 | Sell | $21,253,437.00 | |
| Nov. 4, 2020 | CEO | 49,365 | $60.00 | Sell | $2,961,900.00 | |
| Nov. 4, 2020 | CAO | 31,758 | $60.06 | Sell | $1,907,385.48 |
Insiders are both buying and selling PTC Therapeutics Inc stock.
The insider traders at PTC Therapeutics Inc are: Mark Elliott Boulding, Stuart Walter Peltz, Christine Marie Utter, Neil Gregory Almstead, Emily Luisa Hill, Eric Pauwels, Matthew B Klein, Allan Steven Jacobson, Mark Rothera, Lee Scott Golden, Stephanie Okey, David P Southwell, Claudia De Oliveira Ri Hirawat, Pierre Gravier, Marcio Souza, Dawn Svoronos, Emma Reeve, Hbm Healthcare Investments (Ca, Jerome B Zeldis, Michael Schmertzler, Shane William Charles Kovacs, Alethia Young, Matthew B. Klein, Adam Koppel, Richard Aldrich, Robert J Spiegel, Robert Spiegel, David Southwell, Michael Kranda, and Michael L Kranda
The most active insider trader at PTC Therapeutics Inc is Mark Elliott Boulding with 34 trades.
Stuart Walter Peltz has sold the most PTC Therapeutics Inc stock with a total value of $85,044,720.20.
Adam Koppel has bought the most PTC Therapeutics Inc stock with a total value of $37,500,000.00.
The most recent insider trade for PTC Therapeutics Inc was on April 6, 2026.
The single biggest insider buy for PTC Therapeutics Inc was from Adam Koppel with a total value of $18,750,000.00 on June 25, 2013.
The single biggest insider sell for PTC Therapeutics Inc was from Stuart Walter Peltz with a total value of $21,253,437.00 on Dec. 7, 2020.
